Jan 16, 2012, 08.10 PM | Source: CNBC-TV18
Chairman of Mankind Pharma, Ramesh Juneja, tells CNBC-TV18 that they aim to enter the league of top five in the pharma space in the next three years and reach the top slot by 2016.
Archana Shukla (more)
Reporter, CNBC-TV18 |
Is this an ambitious or realistic vision? Going by its history, it could be realistic to some extent. Mankind Pharma is a closely held company that has almost doubled revenues every two years for six straight years to Rs 2,000 crores. They have followed the lowest drug pricing policy; their strategy has been to keep their prices low to push sales numbers and volumes in the Indian market. However, in a competitive market like the pharmaceutical space where a lot multinational companies come in, this aim could be ambitious.
Going forward, Juneja tells CNBC-TV18 that they plan to add another 1000 people to their workforce within two years. They currently have a field force of 6000 people. He further said that they intend to launch about 35 products every year for the next 2-3 years and are eyeing a growth of about 40-45% in the Indian market.
Watch the accompanying video for more details..
The drugmaker, based in the southern Indian city o
"The formulations facility of the company at Panel
Gland Pharma founders and KKR & Co, who jointly ow
Bal Pharma at its meeting held on April 13, 2016,
Vijay Chopra of enochventures.com is of the view t
Sandeep Wagle of powermywealth.com is of the view
Multi-national drug companies are queuing up to en